UCLA Scientists Develop Off-The-Shelf Immunotherapy for Ovarian Cancer
August 13, 2025
August 13, 2025
LOS ANGELES, California, Aug. 13 (TNSjou) -- The UCLA Health issued the following news release:
* * *
UCLA scientists develop off-the-shelf immunotherapy for ovarian cancer
The team will now seek FDA approval to open a clinical trial for the CAR-NKT cell therapy
*
Ovarian cancer is the leading cause of death among women with gynecological cancers. The current medical playbook -- surgery followed by chemotherapy -- initially shows p . . .
* * *
UCLA scientists develop off-the-shelf immunotherapy for ovarian cancer
The team will now seek FDA approval to open a clinical trial for the CAR-NKT cell therapy
*
Ovarian cancer is the leading cause of death among women with gynecological cancers. The current medical playbook -- surgery followed by chemotherapy -- initially shows p . . .